A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Treatment Acquiring Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on Telegram, where groups with numerous of participants share comparison photos, administration instructions and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.
Some experts said the demand for retatrutide could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Material Elimination
Based on TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Investigations also found communities with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with images of slimming results, glowing testimonials and step-by-step instructions for mixing or administering at home.
Within moments of entering one community, a vendor posted WhatsApp details, where the majority of transactions occur. The seller provided an guidebook and promised shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Product Information and Pricing
Within these groups, posts display black plastic parcels with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at residence with purified liquid, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly significant medical dangers”.
